Related Experiment Video
Updated: Jul 9, 2025

Investigating Intestinal Barrier Breakdown in Living Organoids
Published on: March 26, 2020
Patient, Parent, and Provider Perceptions of Barriers to Pediatric Inflammatory Bowel Disease Care
Jennifer L Dotson1,2, Josh Bricker2, Deena J Chisolm2
1From the Division of Pediatric Gastroenterology, Hepatology and Nutrition, Nationwide Children's Hospital, Columbus, OH.
Insights
Identifying health system barriers for pediatric inflammatory bowel disease (IBD) care is crucial. Patients, families, and providers identified shared and unique challenges, emphasizing the need for multi-stakeholder input to improve IBD management.
Area of Science:
- Pediatric Gastroenterology
- Health Services Research
- Qualitative Health Research
Background:
- Children with inflammatory bowel disease (IBD) face lifelong health challenges influenced by environmental and individual barriers.
- Effective health system interventions for pediatric IBD necessitate a comprehensive strategy involving diverse stakeholders.
Purpose of the Study:
- To identify health system barriers and potential solutions for pediatric IBD care.
- To gather insights from patients, families, and healthcare providers through focus groups.
Main Methods:
- Conducted separate focus groups with English-speaking pediatric patients (ages 9-18) with IBD, their caregivers, and multidisciplinary healthcare providers.
- Utilized a standardized interview guide, recorded and transcribed sessions, and applied content analysis for systematic data classification and theme identification.
Main Results:
- Focus groups included 20 patients, 24 parents, and 19 providers.
- Common concerns across groups included school, care delays, psychosocial issues, and financial burdens.
- Identified potential solutions ranging from education and improved communication to institutional and policy-level changes.
Conclusions:
- Qualitative analysis revealed shared and unique barriers to pediatric IBD care among patients, parents, and providers.
- Emphasized the critical importance of incorporating multiple stakeholder perspectives to effectively address care barriers.
Objectives:
Children with inflammatory bowel disease (IBD) have a significant life-long burden as a result of disease, impacted by environmental and individual barriers. Successful health system interventions require a comprehensive approach, informed by various stakeholders. The main objective was to identify health system barriers and potential solutions from existing patients, families, and providers via focus groups.
Methods:
Participants for the focus groups were existing English-speaking patients (ages 9-18) with IBD, their caregiver(s), and providers including multiple professions (eg, physician, nurse, pediatrician, social worker, care coordinator, scheduler, and psychologist). Separate focus groups were led by experienced personnel for parents, children, and providers, using a standardized interview guide. Sessions were recorded, transcribed, and verified. Using content analysis, we systematically classified data through coding and identified themes.
Results:
Focus groups comprised (a) 3 patient groups (n = 20, 50% female, including 2 younger; mean age = 11.4 ± 1.5 years) and 1 older group (mean age = 15.6 ± 1.3 years), (b) 3 parent groups (n = 24, 83% female), and (c) 2 multidisciplinary provider groups (n = 19). Families shared several common concerns with providers (eg, school, care delay, psychosocial, and financial) but varied on specifics. Some barriers may be addressable through family or staff education, improved communication (eg, care delay/ access, transition), or training (eg, labs and diet), while others may require change at an institutional or policy level (eg, insurance).
Conclusions:
This qualitative analysis identified several barriers to IBD care, some shared, some unique to patients, parents, and providers, highlighting the importance of obtaining multiple stakeholder perspectives when exploring barriers to care.
Related Concept Videos
Barriers to Effective Communication II
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

